White Paper: Drug Development in Oncology
Published December 2022
Abstract:
Cancer is the largest cause of mortality in the world, accounting for around 10 million deaths in 2020.
Cancer is caused by changes in the genome, predominantly in proto-oncogenes, tumour suppressor genes, and DNA repair genes, that lead to the uncontrolled growth and spread of abnormal cells.
This white paper aims to provide a broad overview;of thefollowing key topics in oncology:
- Cancer Statistics
- What Is Cancer?
- Cancer Diagnostics
- Types of Oncology Therapies
- Oncology Drug Development
- Expedited Approval Process for Oncology Products
- Challenges in Oncology Drug Development
- Regulatory Oncology News In 2022
Keywords: oncology, cancer research, genes, TNM, drug development, immunotherapy, CAR T-cell therapy, antibodies, checkpoint inhibitors, precision therapy, pharma news, cancer care, cancer diagnostic, preclinical research, FDA, Health Canada, EMA
Click here to view White paper: Drug Development in Oncology